BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 15600244)

  • 1. Selecting antifungal agents for the treatment of invasive fungal infections in patients with renal failure.
    Moudgal VV; Sobel JD
    Curr Opin Investig Drugs; 2004 Aug; 5(8):873-8. PubMed ID: 15600244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of invasive fungal infections: a role for polyenes.
    Chandrasekar P
    J Antimicrob Chemother; 2011 Mar; 66(3):457-65. PubMed ID: 21172787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent approaches to antifungal therapy for invasive mycoses.
    Mathew BP; Nath M
    ChemMedChem; 2009 Mar; 4(3):310-23. PubMed ID: 19170067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antifungals for systemic use].
    Ruiz-Camps I; Cuenca-Estrella M
    Enferm Infecc Microbiol Clin; 2009 Jun; 27(6):353-62. PubMed ID: 19482382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of solid organ transplant patients with invasive fungal infections: should a combination of antifungal drugs be used?
    Muñoz P; Singh N; Bouza E
    Curr Opin Infect Dis; 2006 Aug; 19(4):365-70. PubMed ID: 16804385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is there a role for polyenes in treating invasive mycoses?
    Cornely OA; Vehreschild JJ; Ullmann AJ
    Curr Opin Infect Dis; 2006 Dec; 19(6):565-70. PubMed ID: 17075332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of systemic mycoses in patients with AIDS.
    Graybill JR
    Arch Med Res; 1993; 24(4):403-12. PubMed ID: 8118165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antifungal drugs.
    Treat Guidel Med Lett; 2005 Feb; 3(30):7-14. PubMed ID: 15671963
    [No Abstract]   [Full Text] [Related]  

  • 9. Design of clinical trials of empiric antifungal therapy in patients with persistent febrile neutropenia: considerations and critiques.
    Sobel JD
    Pharmacotherapy; 2006 Jun; 26(6 Pt 2):47S-54S. PubMed ID: 16716122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of fungal infections following allogeneic stem cell transplantation.
    Narimatsu H; Kami M
    Expert Rev Anti Infect Ther; 2008 Jun; 6(3):373-84. PubMed ID: 18588501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic fungal infections in renal diseases.
    Gandhi BV; Bahadur MM; Dodeja H; Aggrwal V; Thamba A; Mali M
    J Postgrad Med; 2005; 51 Suppl 1():S30-6. PubMed ID: 16519253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antifungal prophylaxis with azoles in high-risk, surgical intensive care unit patients: a meta-analysis of randomized, placebo-controlled trials.
    Vardakas KZ; Samonis G; Michalopoulos A; Soteriades ES; Falagas ME
    Crit Care Med; 2006 Apr; 34(4):1216-24. PubMed ID: 16484923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating prophylaxis of invasive fungal infections in patients with haematologic malignancies.
    Maertens J
    Eur J Haematol; 2007 Apr; 78(4):275-82. PubMed ID: 17241370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. When primary antifungal therapy fails.
    Nucci M; Perfect JR
    Clin Infect Dis; 2008 May; 46(9):1426-33. PubMed ID: 18419447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overview of clinical studies and liposomal formulations of hamycin.
    Bhopale GM
    Hindustan Antibiot Bull; 2007 Feb-2008 Nov; 49-50(1-4):1-4. PubMed ID: 19957536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment options for invasive fungal infections.
    Dodds Ashley ES
    Pharmacotherapy; 2006 Jun; 26(6 Pt 2):55S-60S. PubMed ID: 16716123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of systemic fungal infections: alternatives to itraconazole.
    Herbrecht R; Nivoix Y; Fohrer C; Natarajan-Amé S; Letscher-Bru V
    J Antimicrob Chemother; 2005 Sep; 56 Suppl 1():i39-i48. PubMed ID: 16120633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapy of systemic fungal infections.
    Wu JJ; Pang KR; Huang DB; Tyring SK
    Dermatol Ther; 2004; 17(6):532-8. PubMed ID: 15571503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved outcomes associated with advances in therapy for invasive fungal infections in immunocompromised hosts.
    Metcalf SC; Dockrell DH
    J Infect; 2007 Oct; 55(4):287-99. PubMed ID: 17697716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antifungal treatment in pediatric patients.
    Zaoutis TE; Benjamin DK; Steinbach WJ
    Drug Resist Updat; 2005 Aug; 8(4):235-45. PubMed ID: 16054422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.